3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
4
Pancreatic Neoplasms
2
Malnutrition
2
Rectal Neoplasms
1
Psychological Well-Being
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Motor Activity
1
Liver Neoplasms
1
Glucose Metabolism Disorders
1
Duodenal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
Oxaliplatin
47
Capecitabine
46
Fluorouracil
40
Leucovorin
30
Radiotherapy
25
Irinotecan
20
Chemoradiotherapy
14
Bevacizumab
14
Cetuximab
12
Neoadjuvant Therapy
11
Folfox protocol
11
Chemotherapy, Adjuvant
11
XELOX
10
Laparoscopy
10
Drug Therapy
9
Surgical Procedures, Operative
6
Robotic Surgical Procedures
5
Radiation
5
Mastectomy, Segmental
5
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Panitumumab
4
Gemcitabine
4
FOLFOXIRI protocol
4
durvalumab
3
Simvastatin
3
Magnetic Resonance Spectroscopy
3
Indocyanine Green
3
tislelizumab
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Rectal Neoplasms
×
Nutritional Status
×
Clear all
NCT05305820
2024-03-21
PANO
Dublin City University
Phase NA
Unknown
36 enrolled